Factors That Predict Magnitude, Timing, and Persistence of Placebo-Like Response in Patients With Irritable Bowel Syndrome

Background and Aims: Placebo response impedes the development of novel irritable bowel syndrome (IBS) therapies and the interpretability of randomized clinical trials. This study sought to characterize the magnitude, timing, and durability of IBS symptom relief in patients undergoing a non-drug plac...

Full description

Bibliographic Details
Main Authors: Jeffrey M. Lackner, Brian M. Quigley, Sigal Zilcha-Mano, Christopher Radziwon, Susan S. Krasner, Gregory D. Gudleski, Paul Enck
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Gastro Hep Advances
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2772572323001620